Applications of multi-target computer-aided methodologies in molecular design of CNS drugs
MetadataShow full item record
The discovery of drugs for diseases of the central nervous system (CNS) faces high attrition rates in clinical trials. Neural diseases are extremely complex in nature and typically associated with multiple drug targets. A conception of multi-target directed ligands (MTDL), widely applied to the discovery of cancer pharmaceuticals, may be a perspective solution for CNS diseases. Special bioinformatics approaches have been developed which can assist the medicinal chemists in identification and structural optimization of MTDL. In this review, we analyze the current status of the development of multi-target approaches in quantitative structure-activity relationships (mt-QSAR) for CNS drug discovery; and describes applications of multi-target approaches in molecular modelling (which can be called mt-MM), as well as perspectives for multi-target approaches in bioinformatics in relation to Alzheimer’s disease. © 2018 Bentham Science Publishers.
Showing items related by title, author, creator and subject.
Ligand and structure-based modeling of passive diffusion through the blood-brain barrier (2020) Vilar S.; Sobarzo-Sánchez E.; Santana L.; Uriarte E. (Bentham Science Publishers B.V., 2018)
Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy (2020) Iturriaga-Vásquez P.; Alzate-Morales J.; Bermudez I.; Varas R.; Reyes-Parada M. (Academic Press, 2015)
HCN Channels: New therapeutic targets for pain treatment (2020) Ramírez D.; Zúñiga R.; Concha G.; Zúñiga L. (MDPI AG, 2018)